Evidence map›Paper›PMID 29124902›Full record

Trial reportImmunity, inflammation and disease2018

T-cell responses against rhinovirus species A and C in asthmatic and healthy children.

Cibele M Gaido, Caitlyn Granland, Ingrid A Laing, Peter N Le Souëf, Wayne R Thomas, Andrew J Currie, Belinda J Hales

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Immunity, inflammation and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. The Binary Classification of Protein Kinases.Journal of inflammation research · 2021
    Article
  6. Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  7. Asthma and the Dysregulated Immune Response to Rhinovirus.American journal of respiratory and critical care medicine · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Cibele M GaidoTelethon Kids Institute, The University of Western Australia, Perth, Australia.
Caitlyn GranlandTelethon Kids Institute, The University of Western Australia, Perth, Australia.
Ingrid A LaingTelethon Kids Institute, The University of Western Australia, Perth, Australia.
Peter N Le SouëfSchool of Paediatrics and Child Health, The University of Western Australia, Perth, Australia.
Wayne R ThomasTelethon Kids Institute, The University of Western Australia, Perth, Australia.
Andrew J CurrieSchool of Paediatrics and Child Health, The University of Western Australia, Perth, Australia.
Belinda J HalesTelethon Kids Institute, The University of Western Australia, Perth, Australia.ORCID 0000-0003-2193-3996
The Kids Research Institute Australia · AUMurdoch University · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfections by rhinovirus (RV) species A and C are the most common causes of exacerbations of asthma and a major cause of exacerbations of other acute and chronic respiratory diseases. Infections by both species are prevalent in pre-school and school-aged children and, particularly for RV-C, can cause severe symptoms and a need for hospitalization. While associations between RV infection and asthma are well established, the adaptive immune-mechanisms by which RV infections influence asthma exacerbations are yet to be defined.

objectiveThe aim of this study was to characterize and compare T-cell responses between RV-A and RV-C and to test the hypothesis that T-cell responses would differ between asthmatic children and healthy controls.

methodsA multi-parameter flow cytometry assay was used to characterize the in vitro recall T-cell response against RV-A and RV-C in PBMCs from children with acute asthma (n = 22) and controls (n = 26). The responses were induced by pools of peptides containing species-specific VP1 epitopes of RV-A and RV-C.

resultsRegardless of children's clinical status, all children that responded to the in vitro stimulation (>90%) had a similar magnitude of CD4+ T-cell responses to RV-A and RV-C. However, asthmatic children had a significantly lower number of circulating regulatory T cells (Tregs), and healthy controls had significantly more Tregs induced by RV-A than RV-C. CONCLUSIONS AND CLINICAL RELEVANCE: The comparable recall memory T-cell responses in asthmatic and control children to both RV-A and RV-C show that differences in the antibody and inflammatory responses previously described are likely to be due to regulation, with a demonstrated candidate being reduced regulatory T-cells. The reduced Treg numbers demonstrated here could explain the asthmatic's inability to appropriately control immunopathological responses to RV infections.

Indexed as

AsthmaCoxsackievirus InfectionsImmunologic MemoryAdolescentChildChild, PreschoolEnterovirusFemaleHumansInfantMaleT-Lymphocytes, RegulatoryAsthmaregulatory T-cellsrhinovirusT-cell proliferation

Identifiers

PMID29124902
PMCPMC5818445
OpenAlexW2767559164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.